Pictet Asset Management
AVXL icon

Pictet Asset Management’s Anavex Life Sciences AVXL Stock Holding History

Pictet Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,603
Closed -$69.8K – 2111
2025
Q4 		$69.8K Hold
19,603
– – ﹤0.01% 2054
2025
Q3 		$174K Hold
19,603
– – ﹤0.01% 1912
2025
Q2 		$181K Hold
19,603
– – ﹤0.01% 1847
2025
Q1 		$168K Buy
+19,603
New +$185K ﹤0.01% 1833

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Pictet Asset Management's AVXL Position: Q1 2026 in Review

Pictet Asset Management sold out of Anavex Life Sciences (AVXL) in Q1 2026, closing a stake of 19,603 shares — an estimated $69.8K sold.

Pictet Asset Management first reported a position in AVXL in Q1 2025 and held it in 4 quarters. The position peaked at $181K in Q2 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Pictet Asset Management reported no remaining Anavex Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Pictet Asset Management sold 19,603 Anavex Life Sciences shares in Q1 2026, an estimated $69.8K.
  • Pictet Asset Management first reported a position in Anavex Life Sciences in Q1 2025 and held it in 4 quarters.
  • Pictet Asset Management's Anavex Life Sciences position peaked at $181K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.